Konsepsi Penggantian Kerugian Atas Pemberian Izin Mendirikan Bangunan (Imb) yang Tidak Sesuai dengan Rtrw (Kajian terhadap Pasal 37 Undang-undang No.26 Tahun 2007 Tentang Penataan Ruang)

Pasal 37 Ayat (4),(5) dan (8) Undang-undang No.26 Tahun 2007 Tentang Penataan Ruang mengatakan bahwa IMB harus mengikuti konsep perencanaan yang tertera pada Rencana Tata Ruang Wilayah (RTRW) di setiap daerah dan apabila diketahui IMB tersebut melanggar RTRW maka harus dibatalkan dan dimungkinkan adanya pemberian ganti rugi atas pembatalan IMB tersebut. Fenomena yang terjadi saat ini adalah belum jelas dan belum konkretnya aturan yang ada terkait dengan konsepsi ganti rugi sehingga menyulitkan pihak-pihak yang ingin mengajukan upaya hukum melalui sarana hukum yang paling tepat dan efisien. Berdasarkan penelitian ini, penulis menawarkan sarana hukum administrasi karena dianggap yang paling efektif dan jelas dalam menyelesaikan permasalahan IMB yang dilakukan pembatalan, dikarenakan IMB merupakan Keputusan Tata Usaha Negara (KTUN) yang apabila bermasalah sudah terakomodasi di Pengadilan Tata Usaha Negara, sesuai dengan kompetensinya dan yang paling penting adalah gugatan yang dilakukan, terhadap subjek kewenangan yaitu pejabatnya bukan pribadi dari pejabat tersebut yang bertanggung jawab terhadap kesalahan-kesalahan yang berkaitan dengan ketidaksesuaiannya IMB dengan RTRW. Maka, penulis mengusulkan konsepsi penggantian atas kerugian yang diderita oleh investor atau masyarakat dengan melalui mekanisme penggantian yang dibebankan pada pemerintah daerah melalui Anggaran Pendapatan dan Belanja Daerah (APBD). Sehingga diharapkan dapat mengembalikan hakikat tujuan dan manfaat dari IMB.Kata Kunci : Izin Mendirikan Bangunan (IMB), Rencana Tata Ruang Wilayah (RTRW), Upaya Hukum Administrasi, Ganti Rugi

Synthesis of DPPP- And DPPPEN-Type Bidentate Ligands by Ring-Opening Diphosphination of Methylene- And Vinylcyclopropanes under Visible-Light-Promoted Photoredox Catalysis

A ring-opening diphosphination of methylene- and vinylcyclopropanes with tetraaryldiphosphines (Ar2P-PAr2) has been developed to afford the corresponding 1,3-diphenylphosphinopropane- and 1,3-diphenylphosphinopentane-type bidentate ligands, respectively. The reaction proceeds under bromine cation-initiated, visible-light-promoted photoredox catalysis at ambient temperature. Owing to the ready availability of functionalized diphosphines, the electronically diverse MeO- and CF3-substituted bidentate ligands are also easily prepared.Kato Y., Otomura N., Hirano K., et al. Synthesis of DPPP- And DPPPEN-Type Bidentate Ligands by Ring-Opening Diphosphination of Methylene- And Vinylcyclopropanes under Visible-Light-Promoted Photoredox Catalysis. Journal of Organic Chemistry. 85(9), 5981-5994, (2020), 1 May 2020; © 2020 American Chemical Society. https://doi.org/10.1021/acs.joc.0c00417

Diphosphination of ortho-quinone methide precursors with diphosphines

A fluorine anion-mediated diphosphination of ortho-quinone methide precursors (2-(chloromethyl)silyloxybenzenes) with diphosphines has been developed. The reaction proceeds smoothly under mild conditions (CH2Cl2 solvent, 0 °C) to form the corresponding 2-(phosphinomethyl)oxyphosphinobenzenes, which are potential bidentate ligands in metal catalysis. Additionally, some mechanistic investigations are also performed.Kato Y., Otomura N., Hirano K., et al. Diphosphination of ortho-quinone methide precursors with diphosphines. Tetrahedron Letters 60, 2014 (2019); https://doi.org/10.1016/j.tetlet.2019.06.055

Height Constitutes an Important Predictor of Mortality in End-Stage Renal Disease

Aim. Height is an important determinant of augmentation index (AI) that anticipates cardiovascular prognosis. There is a scanty of the data whether short height predicts survival in patients with end-stage renal diseases, a high risk population. Methods. Fifty two hypertensive patients with type 2 diabetic nephropathy receiving hemodialysis and 52 patients with nondiabetic nephropathy were enrolled. In addition to AI estimated with radial artery tonometry, classical cardiovascular risk factors were considered. Patients were followed for 2 years to assess cardiovascular prognosis. Results. Cox hazards regression revealed that both smoking and shortness in height independently contributed to total mortality and indicated that smoking as well as the presence of left ventricular hypertrophy predicted cardiovascular mortality. Our findings implicated that high AI, the presence of diabetes, and low high-density lipoprotein cholesterol were significant contributors to cardiovascular events. Conclusions. Our findings provide new evidence that shortness in height independently contributes to total mortality in hemodialysis patients

Isolation and characterization of a virus (CvV-BW1) that infects symbiotic algae of Paramecium bursaria in Lake Biwa, Japan

<p>Abstract</p> <p>Background</p> <p>We performed an environmental study of viruses infecting the symbiotic single-celled algae of <it>Paramecium bursaria </it>(<it>Paramecium bursaria Chlorella </it>virus, PBCV) in Lake Biwa, the largest lake in Japan. The viruses detected were all <it>Chlorella variabilis </it>virus (CvV = NC64A virus). One of them, designated CvV-BW1, was subjected to further characterization.</p> <p>Results</p> <p>CvV-BW1 formed small plaques and had a linear DNA genome of 370 kb, as judged by pulsed-field gel electrophoresis. Restriction analysis indicated that CvV-BW1 DNA belongs to group H, one of the most resistant groups among CvV DNAs. Based on a phylogenetic tree constructed using the <it>dnapol </it>gene, CvV was classified into two clades, A and B. CvV-BW1 belonged to clade B, in contrast to all previously identified virus strains of group H that belonged to clade A.</p> <p>Conclusions</p> <p>We conclude that CvV-BW1 composes a distinct species within <it>C. variabilis </it>virus.</p

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy

Cutaneous malignant melanoma is one of the most serious skin cancers and is highly invasive and markedly resistant to conventional therapy. Melanomagenesis is initially triggered by environmental agents including ultraviolet (UV), which induces genetic/epigenetic alterations in the chromosomes of melanocytes. In human melanomas, the RAS/RAF/MEK/ERK (MAPK) and the PI3K/PTEN/AKT (AKT) signaling pathways are two major signaling pathways and are constitutively activated through genetic alterations. Mutations of RAF, RAS, and PTEN contribute to antiapoptosis, abnormal proliferation, angiogenesis, and invasion for melanoma development and progression. To find better approaches to therapies for patients, understanding these MAPK and AKT signaling mechanisms of melanoma development and progression is important. Here, we review MAPK and AKT signaling networks associated with melanoma development and progression

Molecular Network Associated with MITF in Skin Melanoma Development and Progression

Various environmental and genetic factors affect the development and progression of skin cancers including melanoma. Melanoma development is initially triggered by environmental factors including ultraviolet (UV) light, and then genetic/epigenetic alterations occur in skin melanocytes. These first triggers alter the conditions of numerous genes and proteins, and they induce and/or reduce gene expression and activate and/or repress protein stability and activity, resulting in melanoma progression. Microphthalmia-associated transcription factor (MITF) is a master regulator gene of melanocyte development and differentiation and is also associated with melanoma development and progression. To find better approaches to molecular-based therapies for patients, understanding MITF function in skin melanoma development and progression is important. Here, we review the molecular networks associated with MITF in skin melanoma development and progression

Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts

BACKGROUND: Human induced pluripotent stem (iPS) cells are currently used as powerful resources in regenerative medicine. During very early developmental stages, DNA methylation decreases to an overall low level at the blastocyst stage, from which embryonic stem cells are derived. Therefore, pluripotent stem cells, such as ES and iPS cells, are considered to have hypo-methylated status compared to differentiated cells. However, epigenetic mechanisms of "stemness" remain unknown in iPS cells derived from extra-embryonic and embryonic cells. METHODOLOGY/PRINCIPAL FINDINGS: We examined genome-wide DNA methylation (24,949 CpG sites covering 1,3862 genes, mostly selected from promoter regions) with six human iPS cell lines derived from human amniotic cells and fetal lung fibroblasts as well as two human ES cell lines, and eight human differentiated cell lines using Illumina's Infinium HumanMethylation27. A considerable fraction (807 sites) exhibited a distinct difference in the methylation level between the iPS/ES cells and differentiated cells, with 87.6% hyper-methylation seen in iPS/ES cells. However, a limited fraction of CpG sites with hypo-methylation was found in promoters of genes encoding transcription factors. Thus, a group of genes becomes active through a decrease of methylation in their promoters. Twenty-three genes including SOX15, SALL4, TDGF1, PPP1R16B and SOX10 as well as POU5F1 were defined as genes with hypo-methylated SS-DMR (Stem cell-Specific Differentially Methylated Region) and highly expression in iPS/ES cells. CONCLUSIONS/SIGNIFICANCE: We show that DNA methylation profile of human amniotic iPS cells as well as fibroblast iPS cells, and defined the SS-DMRs. Knowledge of epigenetic information across iPS cells derived from different cell types can be used as a signature for "stemness" and may allow us to screen for optimum iPS/ES cells and to validate and monitor iPS/ES cell derivatives for human therapeutic applications

Open Abdominal Management Among Non-Trauma Patients: The Appropriate Duration and a New Clinical Index

Purpose Despite widespread adoption of open abdominal management (OAM), there is currently no threshold criterion for OAM duration for non-trauma patients. Moreover, there is a positive relationship between morbidity and the duration of OAM, but an uncertain relationship with patients’ age. Therefore, a novel clinical index for the duration of open abdominal management (IDOM) was developed based on the patient’s age and risk of severe complications following OAM to indicate the maximum tolerable number of days of OAM based on the individual’s age. The utility of this new index was evaluated. Methods This retrospective study included 65 non-trauma patients managed with an open abdomen (OA) from August 2015 to August 2018. The IDOM was developed based on the patient’s age. The result indicated the maximum number of OA days. Patients’ demographic and operative variables were examined and patient data was assigned to one of two groups according to whether the actual number of OA days was above or below the calculated IDOM. Prevalence of complications between these groups was compared. Measures of validity were employed to assess the utility of the IDOM for patient complications. Results Sixty-five patients were included. The above-the calculated IDOM group exhibited a significantly longer OA and higher rates of wound complications and postoperative respiratory complications compared with the below the calculated IDOM group. The IDOM predicted the incidence of OA-related complications with a sensitivity of 72.4%, and a specificity of 80.6%. Conclusion The IDOM is a potentially useful tool for appropriate duration at the outset of OA